Biblio Discovery — Demo Discovery Service

6 hasil untuk "David Liebner"

Menampilkan 1–6 · 0,33 detik · RSS

  1. Artikel Jurnal

    Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

    Konstantin Shilo; Peter J. Kneuertz; David Liebner dkk.

    Frontiers in Oncology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    Solid organ malignancies have been reported in survivors of Hodgkin lymphoma treated with chemoradiation; however, to the best of our knowledge no cases of pulmonary synovial sarcoma have been documented in the literature in this cohort. We herein provide a detailed description of synovial sarcoma…

  2. Artikel Jurnal

    Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma

    Umal Azmat; David Liebner; Amy Joehlin-Price dkk.

    Case Reports in Endocrinology, Vol. 2016 · 2016 · Inggris · DOAJ Scopus

    Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves’ disease, however, has been rarely reported with this medication. Here we report a case of Graves’ disease diagnosed after initiation of ipilimumab in a patient with…

  3. Artikel Jurnal

    Esophageal Gastrointestinal Stromal Tumor With MKRN1-BRAF Fusion: A Rare Mediastinal Case

    Bradley Kruithoff, DO; Lauren Beard, OMS-II; David Liebner, MD dkk.

    Annals of Thoracic Surgery Short Reports, Vol. 4 No. 2 · 2026 · Inggris · DOAJ Scopus

    Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms typically involving the upper gastrointestinal tract. Most GISTs are driven by activating mutations in the KIT or PDGFRA genes, which are primary molecular markers for diagnosis and treatment. In addition, CD117 and DOG1…

  4. Artikel Jurnal

    Clinical markers of immunotherapy outcomes in advanced sarcoma

    Marium Husain; Dionisia Quiroga; Han Gil Kim dkk.

    BMC Cancer, Vol. 23 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Despite immunotherapy’s promise in oncology, its use for sarcoma remains challenging. There are no sarcoma-specific biomarkers for immune checkpoint inhibitors (ICI). Previously, we reported our institutional experience highlighting ICI activity in 29 patients with sarcoma. In…

  5. Artikel Jurnal

    Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

    Alex Soupir; Oscar E. Ospina; Oliver Hampton dkk.

    Nature Communications, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Given their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340…